TrialThe Lancet. Oncology2015
Organ preservation for clinical T2N0 distal rectal cancer using neoadjuvant chemoradiotherapy and local excision (ACOSOG Z6041): results of an open-label, single-arm, multi-institutional, phase 2 trial.
Julio Garcia-Aguilar et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
163 papers cite itlatest 60 shown
this paperpooled ittrialcites it